Invention Grant
US09458235B2 Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptides
有权
用CX3CR1结合多肽治疗CX3CR1相关疾病的方法
- Patent Title: Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptides
- Patent Title (中): 用CX3CR1结合多肽治疗CX3CR1相关疾病的方法
-
Application No.: US14682131Application Date: 2015-04-09
-
Publication No.: US09458235B2Publication Date: 2016-10-04
- Inventor: Sanjaya Singh , Alisa K. Waterman , Erik Depla , Toon Laeremans , Diane Van Hoorick , Cedric Jozef Néotère Ververken
- Applicant: Boehringer Ingelheim International GmbH
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Edward S. Lazer
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61P13/12 ; C07K16/28 ; A61K39/00

Abstract:
The present invention relates to CX3CR1-binding polypeptides, in particular polypeptides comprising specific immunoglobulin domains. The invention also relates to nucleic acids encoding such polypeptides; to methods for preparing such polypeptides; to host cells expressing or capable of expressing such polypeptides; to compositions comprising such polypeptides; and to uses of such polypeptides or such compositions, in particular for prophylactic, therapeutic and diagnostic purposes.
Public/Granted literature
- US20150239971A1 CX3CR1-BINDING POLYPEPTIDES Public/Granted day:2015-08-27
Information query